Malta - englanti - Medicines Authority

bio products laboratory limited dagger lane, elstree hertfordshire, wd6 3bx, united kingdom - factor viii, human - powder and solvent for solution for injection - factor viii, human 25 iu/ml - antihemorrhagics

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

bio products laboratory ltd - factor viii; von willebrand factor - powder and solvent for solution for injection - 500unit ; 1000unit

Yhdistynyt kuningaskunta - englanti - MHRA (Medicines & Healthcare Products Regulatory Agency)

bio products laboratory ltd - von willebrand factor; factor viii - powder and solvent for solution for injection - 500unit ; 250unit

Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

germax sdn. bhd. - factor viii fraction, dried -

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - dried factor viii fraction 500 [iu]; von willebrand's factor : ristocetin cofactor 1000 [iu] - injection with diluent - 500 iu - active: dried factor viii fraction 500 [iu] von willebrand's factor : ristocetin cofactor 1000 [iu] excipient: albumin calcium chloride dihydrate plasma protein sodium chloride sodium citrate dihydrate sucrose trometamol water for injection - biostate® is indicated for: · the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - dried factor viii fraction 500 [iu]; von willebrand's factor : ristocetin cofactor 1000 [iu] - injection with diluent - 500 iu - active: dried factor viii fraction 500 [iu] von willebrand's factor : ristocetin cofactor 1000 [iu] excipient: albumin calcium chloride dihydrate plasma protein sodium chloride sodium citrate dihydrate sucrose trometamol water for injection - biostate® is indicated for: · the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated

Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

germax sdn. bhd. - factor viii fraction, dried -

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

seqirus (nz) ltd - factor viii, human 250 [iu] (factor viii ex nz) - injection with diluent - 250 iu/10ml - active: factor viii, human 250 [iu] (factor viii ex nz) excipient: chloride citrate sodium sucrose trometamol water for injection

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - dried factor viii fraction 1000 [iu]; von willebrand's factor : ristocetin cofactor 2000 [iu] - injection with diluent - 1000 iu - active: dried factor viii fraction 1000 [iu] von willebrand's factor : ristocetin cofactor 2000 [iu] excipient: albumin calcium chloride dihydrate plasma protein sodium chloride sodium citrate dihydrate sucrose trometamol water for injection - biostate® is indicated for: · the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - dried factor viii fraction 250 [iu]; von willebrand's factor : ristocetin cofactor 500 [iu] - injection with diluent - 250 iu - active: dried factor viii fraction 250 [iu] von willebrand's factor : ristocetin cofactor 500 [iu] excipient: albumin calcium chloride dihydrate plasma protein sodium chloride sodium citrate dihydrate sucrose trometamol water for injection - biostate® is indicated for: · the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated